In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

The devil is in the details?, or from when one should count the 5-year period, during which it is possible not to use one’s trade mark without consequences?

Our clients frequently ask the question when exactly the obligation to start to use a Czytaj dalej

WIPR – JURISDICTION REPORT: POLAND

We recommend reading the latest report prepared by World IP Review, summarizing the changes in Czytaj dalej

Upcoming changes in the judicial system in the scope of intellectual property

The changes in the judicial system concerning intellectual property matters have been widely discussed for Czytaj dalej